Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125227511 | 12522751 | 1 | I | 2006 | 20160621 | 20160701 | 20160701 | EXP | CZ-ELI_LILLY_AND_COMPANY-CZ201606011054 | ELI LILLY AND CO | 0.00 | M | Y | 0.00000 | 20160701 | MD | CZ | CZ |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125227511 | 12522751 | 1 | PS | OLANZAPINE. | OLANZAPINE | 1 | Oral | 20 MG, UNKNOWN | Y | 20592 | 20 | MG | |||||||
| 125227511 | 12522751 | 2 | SS | OLANZAPINE. | OLANZAPINE | 1 | Oral | 5 MG, EACH EVENING | Y | 20592 | 5 | MG | QD | ||||||
| 125227511 | 12522751 | 3 | SS | OLANZAPINE. | OLANZAPINE | 1 | Intramuscular | UNK, UNKNOWN | Y | 0 | |||||||||
| 125227511 | 12522751 | 4 | SS | OLANZAPINE. | OLANZAPINE | 1 | Unknown | UNK, UNKNOWN | Y | 0 | |||||||||
| 125227511 | 12522751 | 5 | SS | MIRTAZAPINE. | MIRTAZAPINE | 1 | Unknown | 45 MG, UNKNOWN | Y | 0 | 45 | MG | |||||||
| 125227511 | 12522751 | 6 | SS | CITALOPRAM | CITALOPRAM HYDROBROMIDE | 1 | Unknown | 20 MG, UNKNOWN | U | 0 | 20 | MG | |||||||
| 125227511 | 12522751 | 7 | C | RISPERIDONE. | RISPERIDONE | 1 | Unknown | UNK, UNKNOWN | Y | 0 | |||||||||
| 125227511 | 12522751 | 8 | C | ARIPIPRAZOL | ARIPIPRAZOLE | 1 | Unknown | UNK, UNKNOWN | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125227511 | 12522751 | 3 | Product used for unknown indication |
| 125227511 | 12522751 | 5 | Psychotic disorder |
| 125227511 | 12522751 | 6 | Suicide attempt |
| 125227511 | 12522751 | 7 | Product used for unknown indication |
| 125227511 | 12522751 | 8 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125227511 | 12522751 | OT |
| 125227511 | 12522751 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125227511 | 12522751 | Apathy | |
| 125227511 | 12522751 | Cognitive disorder | |
| 125227511 | 12522751 | Drug intolerance | |
| 125227511 | 12522751 | Fatigue | |
| 125227511 | 12522751 | Flat affect | |
| 125227511 | 12522751 | Metabolic disorder | |
| 125227511 | 12522751 | Overdose | |
| 125227511 | 12522751 | Performance status decreased | |
| 125227511 | 12522751 | Psychotic disorder | |
| 125227511 | 12522751 | Schizophrenia | |
| 125227511 | 12522751 | Sedation | |
| 125227511 | 12522751 | Sluggishness | |
| 125227511 | 12522751 | Stupor | |
| 125227511 | 12522751 | Suicide attempt | |
| 125227511 | 12522751 | Weight increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125227511 | 12522751 | 1 | 2006 | 0 | ||
| 125227511 | 12522751 | 4 | 2015 | 0 |